| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.036 | 0.5 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.027 | 0.6 |